The clinical relevance of newly described nontuberculous mycobacteria is often unclear. We report a case of pulmonary infection caused by Mycobacterium hassiacum in an immunocompetent patient in Austria who had chronic obstructive pulmonary disease. Antimicrobial drug susceptibility testing showed low MICs for macrolides, aminoglycosides, fluoroquinolones, tetracyclines, imipenem, and linezolid.
Keywords: 16S rRNA; Austria; Mycobacterium hassiacum; NTM-PD; antimycobacterials; bacteria; nontuberculous mycobacterial pulmonary disease; tuberculosis and other mycobacteria.